Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.
A groundbreaking £1.65million gene therapy treatment offering hope for sickle cell disease patients has been approved for use ...
The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal ...
The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.
President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...
The exchanges show how RFK Jr. has failed to update his views on important health issues, even when presented with new ...
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
The Exa-cel gene therapy treatment is at the forefront of medical technology. It takes the person’s DNA and “edits” out the faulty sickle gene. It’s expensive, too. According to the manufacturer, ...
Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...
The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...
Medical Aesthetics Machine Market The growing popularity of non-invasive cosmetic procedures is a major driver of the Global Medical Aesthe ...